161 related articles for article (PubMed ID: 29029665)
1. Mohs Micrographic Surgery: Key Pharmacologic Considerations.
Fischer D; Orlando P; Shane-McWhorter L
Consult Pharm; 2017 Aug; 32(8):450-457. PubMed ID: 29029665
[TBL] [Abstract][Full Text] [Related]
2. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
3. [Anticoagulation in atrial fibrillation].
Binggeli C; Brunckhorst CB
Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
[TBL] [Abstract][Full Text] [Related]
4. [New oral anticoagulants for prophylaxis of stroke : Results of an expert conference on practical use in geriatric patients].
Bahrmann P; Harms F; Schambeck CM; Wehling M; Flohr J
Z Gerontol Geriatr; 2016 Jul; 49(5):460-1. PubMed ID: 27357589
[No Abstract] [Full Text] [Related]
5. AFib in special populations.
French WJ
Am J Med; 2014 Apr; 127(4):e17-8. PubMed ID: 24655745
[TBL] [Abstract][Full Text] [Related]
6. [Thromboembolism prophylaxis in old age].
Röhrig G; Kolb G;
Z Gerontol Geriatr; 2018 Apr; 51(3):349-363. PubMed ID: 29623408
[TBL] [Abstract][Full Text] [Related]
7. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192
[TBL] [Abstract][Full Text] [Related]
8. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
[TBL] [Abstract][Full Text] [Related]
9. Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.
Guo Y; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):71-8. PubMed ID: 23466969
[TBL] [Abstract][Full Text] [Related]
10. New oral anticoagulants in elderly patients with atrial fibrillation.
Deedwania PC
Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212
[TBL] [Abstract][Full Text] [Related]
11. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
[TBL] [Abstract][Full Text] [Related]
12. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project.
Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L
Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
14. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
Fernandez MM; von Schéele B; Hogue S; Kwong WJ
Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
[TBL] [Abstract][Full Text] [Related]
15. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
[TBL] [Abstract][Full Text] [Related]
16. Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation.
Myat A; Ahmad Y; Haldar S; Tantry US; Redwood SR; Gurbel PA; Lip GY
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1029-49. PubMed ID: 23984927
[TBL] [Abstract][Full Text] [Related]
17. The introduction of novel oral anticoagulants in 2009 has been rightly heralded as a major therapeutic breakthrough.
Pachinger O
Wien Klin Wochenschr; 2014 Nov; 126(21-22):691. PubMed ID: 25398295
[No Abstract] [Full Text] [Related]
18. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
19. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
Lane DA; Lip GY
Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
[No Abstract] [Full Text] [Related]
20. [Anticoagulation in atrial fibrillation. Strategies in special situations].
Volkmann H; Walter M; Walter C; Vetter S
Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
